Group Admins
Fenbendazole 150 mg is an anthelmintic (deworming) medication primarily used in veterinary medicine, especially for treating gastrointestinal parasites in animals. However, recent off-label interest has emerged regarding its potential use in humans, particularly due to anecdotal reports suggesting possible benefits in managing certain types of cancer. Though not officially approved for human use, some individuals have explored fenbendazole as a supplementary therapy based on its anti-parasitic, anti-inflammatory, and purported anti-cancer properties.
In theory, Fenbendazole 150mg works by disrupting the microtubule function within cells, inhibiting the parasite’s ability to absorb nutrients, leading to its death. This same mechanism has led researchers to investigate its effects on rapidly dividing human cells, such as those found in tumors. Preliminary lab studies have shown some promise in this area, particularly in targeting cancer cell metabolism, but human clinical trials are limited and inconclusive.